Skip to main content

New Use of Anti-Epileptic Drugs and Agranulocytosis

    Basic Details
    Date Posted
    Medical Product
    anti-epileptic drug (AED)
    Health Outcome(s)
    absolute neutrophil count (ANC)

    Modular program-based one-time assessment of diagnoses of agranulocytosis, Absolute Neutrophil Count (ANC) laboratory results, and agranulocytosis diagnoses within 14 days of an ANC result following new use of several anti-epileptic drugs. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2006 to June 30, 2013. Modular programs are adaptable standardized programs. Results were generated using Modular Program 3, version 1.0; click here for more information. Queries were distributed in August 2014. This report includes data from 10 Data Partners.
    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to
    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    Time Period
    January 1, 2006 - June 30, 2013
    Analysis Type
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)